Rituximab-induced Crohn's disease in a child with refractory nephrotic syndrome

Pediatr Int. 2022 Jan;64(1):e15285. doi: 10.1111/ped.15285.

Authors

Shuhei Machida¹, Soya Kobayashi¹, Toshifumi Yodoshi^{1

2}

Affiliations

¹ Department of Pediatrics, Okinawa Chubu Hospital, Okinawa, Japan.
² Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children, Toronto, ON, Canada.

PMID: 36271771
DOI: 10.1111/ped.15285

No abstract available

Keywords: Crohn's disease; inflammatory bowel disease; nephrotic syndrome; rituximab; ustekinumab.

MeSH terms

Child
Crohn Disease* / complications
Crohn Disease* / drug therapy
Family
Humans
Nephrotic Syndrome* / diagnosis
Nephrotic Syndrome* / drug therapy
Remission Induction
Rituximab / adverse effects

Substances

Rituximab